PBSV (Pharma-Bio Serv) Other Long Term Assets: $0.12 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBSV Pharma-Bio Serv Inc PBSV
45 GF Score
Price $0.40
GF Value $0.61
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Pharma-Bio Serv Other Long Term Assets?

Pharma-Bio Serv PBSV -11.11% 45 Other Long Term Assets is $0.12 Mil as of Apr. 2026. GuruFocus rates PBSV with a GF Score™ of 45/100 and a GF Value™ of $0.61 (Possible Value Trap). The stock has 2 warning signs investors should review.

Pharma-Bio Serv's other long-term assets for the quarter that ended in Apr. 2026 was $0.12 Mil.

Pharma-Bio Serv's quarterly other long-term assets increased from Oct. 2025 ($0.12 Mil) to Jan. 2026 ($0.12 Mil) but then stayed the same from Jan. 2026 ($0.12 Mil) to Apr. 2026 ($0.12 Mil).

Pharma-Bio Serv's annual other long-term assets increased from Oct. 2023 ($0.11 Mil) to Oct. 2024 ($0.23 Mil) but then declined from Oct. 2024 ($0.23 Mil) to Oct. 2025 ($0.12 Mil).

Pharma-Bio Serv Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Pharma-Bio Serv's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma-Bio Serv Other Long Term Assets Chart

Pharma-Bio Serv Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.13 0.11 0.23 0.12

Pharma-Bio Serv Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.23 0.12 0.12 0.12
PBSV
45GF Score
Pharma-Bio Serv Inc PBSV
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma-Bio Serv Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.12 Mil mean?
Pharma-Bio Serv (PBSV) has a Other Long Term Assets of $0.12 Mil as of Apr. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Pharma-Bio Serv and its competitors.
Is Pharma-Bio Serv's Other Long Term Assets too high?
Pharma-Bio Serv's current Other Long Term Assets is $0.12 Mil. Overall, Pharma-Bio Serv has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Other Long Term Assets compare to HCTI and BFRG?
Pharma-Bio Serv's Other Long Term Assets of $0.12 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Pharma-Bio Serv and its competitors. Pharma-Bio Serv's current Other Long Term Assets is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Possible Value Trap. The stock's GF Value™ is $0.61, compared to a current price of $0.40 — trading 34.4% below its estimated fair value. The current Other Long Term Assets is $0.12 Mil. Pharma-Bio Serv's overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Other Long Term Assets is $0.12 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma-Bio Serv (PBSV) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued. The current stock price of $0.40 is trading 34.4% below its estimated GF Value™ of $0.61. GuruFocus considers Pharma-Bio Serv to be Possible Value Trap.

Key valuation signals for PBSV:

  • Other Long Term Assets: $0.12 Mil
  • GF Value™: $0.61 vs. price of $0.40 (34.4% below fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma-Bio Serv Business Description

Address No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
45GF Score

Get the complete analysis for PBSV

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.61
GF Value